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Abstract
Background: The presence of conceptus alloantigens necessitates changes in maternal immune function. One player in this
process may be the macrophage. In the cow, there is large-scale recruitment of macrophages expressing CD68 and CD14 to
the uterine endometrium during pregnancy.
Methodology/Principal Findings: In the present study, the function of endometrial macrophages during pregnancy was inferred
by comparison of the transcriptome of endometrial CD14
+ cells isolated from pregnant cows as compared to that of blood CD14
+
cells. The pattern of gene expression was largely similar for CD14
+cells from both sources, suggesting that cells from both tissues are
from the monocyte/macrophage lineage. A total of 1,364 unique genes were differentially expressed, with 680 genes upregulated in
endometrial CD14
+ cells as compared to blood CD14
+ cells and with 674 genes downregulated in endometrial CD14
+ cells as
compared to blood CD14
+cells. Twelve genes characteristic of M2 activated macrophages (SLCO2B1,GATM,MRC1,ALDH1A1,PTGS1,
RNASE6, CLEC7A, DPEP2, CD163, CCL22, CCL24,a n dCDH1) were upregulated in endometrial CD14
+ cells. M2 macrophages play roles
in immune regulation, tissue remodeling, angiogenesis and apoptosis. Consistent with a role in tissue remodeling, there was over-
representation of differentially expressed genes in endometrium for three ontologies related to proteolysis. A role in apoptosis is
suggested by the observation that the most overrepresented gene in endometrial CD14
+ cells was GZMA.
Conclusions: Results indicate that at least a subpopulation of endometrial macrophages cells differentiates along an M2
activation pathway during pregnancy and that the cells are likely to play roles in immune regulation, tissue remodeling,
angiogenesis, and apoptosis.
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Introduction
Pregnancy leads to immunological adjustments in the mother
that facilitate survival of the conceptus. One of these adjustments,
recruitment of macrophages to the pregnant endometrium, occurs
in a wide range of mammalian species including the mouse [1],
human [2–4], cynomologus and vervet monkeys [5], sheep [6] and
cow [7,8]. The role of endometrial macrophages is not known and
may vary depending upon anatomical location. In cattle,
macrophages are rare in the endometrium in nonpregnant females
but accumulate in large number during pregnancy [7]. Endome-
trial macrophages in the pregnant cow are regionally differenti-
ated, with macrophages in the interplacentomal endometrium
being largely CD68
+CD14
+MHC class II
- and often positive for
CD11b while the less-numerous macrophages in the caruncular
septa of placentomes are largely CD68
+CD14
+MHC class II
+ and
have little or no expression of CD11b [8].
One role for endometrial macrophages is participation in host
defense. Indeed, endometrial macrophages increase in number in the
pregnant cow after experimental infection with Neosporacaninum[9]. A
role for macrophages in clearing bacteria after parturition or in the
expulsion of the conceptus is also a possibility because macrophages
accumulate with impending parturition [10,11]. Activation of a local
immune response in response to intrauterine infection can also turn
macrophages into pregnancy foes that induce fetal resorption [12].
Endometrial macrophages in the human have been proposed to
participate in vascular remodeling since they produce vascular
endothelial growth factor [13] and macrophage accumulation in the
uterus is abnormal in women with pre-eclampsia [14]. Macrophages
can also promote trophoblast function by clearing apoptotic cells and
secreting cytokines that regulate the apoptotic process [15]. In
addition, macrophages can metabolize placental lactogen [16] and
may participate inregulation of concentrations of thishormoneat the
fetal-maternal interface. Given the potential antigenicity of the
conceptus by virtue of inheritance of paternal antigens and, at least in
cows, the expression of classical MHC proteins on the placenta
[17,18], a role for macrophages in limiting activation of anti-
conceptus immune responses is also possible.
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13213Macrophages can follow different differentiation pathways when
activated by cytokines. Exposure to interferon-c (IFNG), tumor
necrosis factor-a and/or lipopolysaccharide leads to activation
along the classical or M1 activation pathway to produce a
macrophage that promotes inflammation and cytotoxicity while
exposure to interleukin-4 (IL4) and -13 (IL13) leads to activation via
the alternative or M2 activation pathway to produce a macrophage
that directs immunosuppression and wound healing [19,20]. The
M2 activation pathway can be divided into three subpathways. The
M2a pathway represents macrophages that are stimulated by IL13
and IL4; the M2b pathway involves macrophage differentiation
under the influence of immune complexes via toll-like receptor and
IL1 receptor; and M2c macrophages differentiate under the
influence of IL10 and transforming growth factor-b (TGFB) or
glucocorticoid hormones [20]. Endometrial macrophages in
humans and mice have been reported to have some characteristics
of M2 activation [2,4,21]. It remains possible that endometrial
macrophages possess a unique activation status.
In the experiment reported herein, likely functions of macro-
phages residing in the interplacentomal endometrium of pregnant
cows were determined through use of global analysis of the
macrophage transcriptome to characterize the pattern of gene
expression and identify functional pathways that are activated or
inhibited in endometrial macrophages compared with monocytes
in blood. We hypothesized that macrophages in the pregnant
endometrium would express genes that support placental growth
(angiogenesis and tissue remodeling) and that are indicative of a
M2 phenotype that signifies a role in modulation of immune
responses towards fetal antigens.
Results
Purification of Endometrial and Blood CD14
+ Cells
The final preparation of endometrial CD14
+ cells had a purity
of 90–95% based on flow cytometry while blood CD14
+ cells were
98–99% pure (Figure 1).
Figure1.RepresentativeacquisitiondotplotsforCD14
+cellsinendometriumandperipheralbloodasdeterminedbyflow cytometry.
Shown are analyses for dispersed endometrial cells and peripheral blood mononuclear cells from a cow at ,Day 230 of pregnancy before (A) and after
two rounds of cell sorting (B). The y-axis depicts side scatter characteristics (SSC) to analyze cells on the basis of granularity and the x-axis depicts
intensity of fluorescence (FL1) associated with anti CD14. The circles and rectangles in the dot plots identify CD14
+ cells targeted for sorting.
doi:10.1371/journal.pone.0013213.g001
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+
Cells
The transcriptomes of blood and endometrial CD14
+ cells were
compared using a bovine whole genome array that covers
,19,500 bovine genes. As shown from results of hierarchical
cluster analysis (Figure 2A), the pattern of gene expression was
largely similar for CD14
+ cells from both sources, suggesting that
cells from both tissues are from the monocyte/macrophage
lineage. There were 13,422 genes expressed in both cell types,
450 genes exclusively expressed by endometrial CD14
+ cells and
1,386 genes expressed exclusively by blood CD14
+ cells.
(Figure 2B).
Identification of Differentially Expressed Genes
Criteria for identifying differentially expressed genes was a level
of significance of P#0.05, a fold change .2, and a maximum false
discovery rate of 0.01. A total of 1,364 unique genes were
differentially expressed, with 680 genes upregulated in endometrial
CD14
+ cells as compared to blood CD14
+ cells and with 674 genes
downregulated in endometrial CD14
+ cells as compared to blood
CD14
+ cells (i.e, upregulated in blood). Of these differentially
expressed genes, 598 of the 680 upregulated genes in the
endometrium and 529 of the 674 upregulated in the blood could
be annotated. A list of the differentially-expressed genes, including
least-squares means for endometrium and blood, fold-change
values and P values is presented in File S1.
The gene with the greatest fold-increase (120.2 fold) in the
endometrium was granzyme A (gzma; NM_001001142), a serine
proteinase enzyme produced by cytotoxic T cells and natural killer
cells, which induces apoptosis of target cells. Transcripts for a
second granzyme A gene, (GZMA, NM_001099095) was increased
in endometrium by 5.8 fold in endometrial CD14
+ cells while
another granzyme gene, GZMB, was upregulated 22.5 fold. There
were other genes characteristically expressed in immune cells that
were among the top 100 overexpressed genes such as stannio-
calcin-1 (STC1; 110.4 fold), heat shock protein70 B (HSPA6; 55.6-
fold) and macrophage scavenger receptor A (MSR1; 7.2 fold).
Several growth factor and cytokine genes were upregulated in
endometrium (File S1). These include connective tissue growth
factor (CTGF;39.3 fold), insulin-like growth factor binding protein-
6( IGFBP6; 18.0 fold), endothelial cell-specific molecule 1 (ESM;
46.9 fold), chemokine (C-X-C motif) ligand 14 (CXCL14; 36.7
fold), and chemokine (C-C motif) ligand 22 (CCL22; 29.0 fold).
Additionally, there were molecules involved in complement system
Figure 2. Graphical representation of differentially regulated genes in endometrial and blood CD14+ cells. (A) Hierarchical cluster
representing the global gene expression of endometrial and blood CD14
+ cells. Each sample is identified by tissue source [endometrium (E) and
blood (B)], dye (Cy3 vs Cy5), replicate (A vs M), and cow number (1 to 5). (B) Venn diagram characterizing expressed genes in endometrium and blood.
Circles represent the genes expressed in both cell types (brown; 13,422 genes), genes exclusively expressed by endometrial CD14
+ cells (green; 450
genes) and genes expressed exclusively by blood CD14
+ cells (red; 1386 genes). (C) Venn diagram characterizing the expression of immune genes
reported by Jensen et al. [22] to be expressed by the bovine macrophages. Circles represent the genes expressed in both cell types (brown; 47
genes), genes exclusively expressed by endometrial CD14
+ cells (green; 2 gene) and genes expressed exclusively by blood CD14
+ cells (red; 3 genes).
An additional 4 genes reported by Jensen et al. [22] were not identified in either cell population.
doi:10.1371/journal.pone.0013213.g002
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(VSIG4; 20.4 fold), clusterin (CLU; 27.1 fold), and complement
component (C1QA; 19.1 fold)], genes related to cell adhesion
[nectin-3 (PVRL3; 19.5 fold), claudin-1 (CLDN1; 28.1 fold), and
claudin-8 (CLDN8; 44.6 fold)], and genes involved in responses to
hypoxia [aryl-hydrocarbon receptor nuclear translocator 2
(ARNT2; 22.4 fold), angiogenin (ANG; 38.1 fold) and L-arginine:-
glycine amidinotransferase (GATM; 30.8 fold)].
Several genes characteristically produced by the placenta were
upregulated in endometrial CD14
+ cells (File S1). These genes
include several members of the pregnancy-associated glycoprotein
family (in order of fold change, PAG3, PAG6, PAG15, PAG21,
PAG5, PAG1B, PAG4, PAG10, PAG7, PAG17, PAG11, PAG9,
PAG18; 72.2 to 3.6 fold increase), placental lactogen (CSH1; 43.8
fold), and a group of genes encoding prolactin-related proteins
(PRP3, PRP6, PRP15, PRP1, PRP8; 54.3 to 30.7 fold increase).
Uterine milk protein precursor, a product of uterine epithelium
also called uterine serpin (SERPINA14), was also highly expressed
in endometrial CD14
+ cells (92.5 fold higher than blood). Thus, it
is likely that some cells in the endometrial CD14
+ cell preparation
were of placental and endometrial epithelial origin.
Calcitonin-related polypeptide b, transcript variant 2 (CALCB)
was the gene most upregulated in blood CD14
+ cells (23.8 fold
higher in blood) (File S1). This gene encodes for a hormone
involved in vascular homeostasis. Other clusters of genes
upregulated in blood are involved in inflammatory and immune
response process such as pentraxin-related gene (PTX3; 17.9 fold),
cytokine-cytokine interaction, chemokine (C-C motif) receptor 3
(CCR3; 19.8 fold), interleukin 8 receptor beta (IL8RB; 14.5 fold)
and interleukin 18 receptor 1 (IL18R1; 6.2 fold). Moreover,
transcripts for B-lymphocyte antigen CD20 (MS4A1; 16.8 fold)
and B-cell receptor CD22 precursor (CD22; 5.9 fold) were
upregulated in the blood. There was also upregulation of genes
involved in signal transduction including, among others, mitogen-
activated protein kinase kinase kinase kinase (MAP4K2; 5.9 fold)
and microtubule-associated protein-1S (MAP1S; 6.3 fold).
To address the question of whether CD14
+ endometrial cells
express genes that are characteristic of bovine macrophages, we
compared the transcriptome of endometrial and blood CD14
+
cells to the list of genes identified by Jensen et al. [22] as being
expressed by bovine macrophages (Figure 2C). Of the 56 immune
genes reported in that paper to be expressed in bovine
macrophages, 52 were expressed by endometrial and blood
CD14
+ cells. Of these 52 genes, 5 were differentially expressed.
Two genes were upregulated in endometrium [CD63 antigen
(CD63) and CCL8] and three were upregulated in blood [CD80;
STAT1; apoptosis (APO1) antigen 1 (FAS), member 6 (TNFRSF6)].
Gene Ontology Analysis of Differentially Expressed Genes
The FatiGo web tool was used to perform a functional
enrichment analysis to determine ontologies in which differentially
regulated genes were more frequent in either endometrium or
blood (Table S1). A total of 10 ontology classes were significant. In
4 cases, there was over-representation of differentially-expressed
genes in endometrium (peptidase activity, endopeptidase activity,
proteolysis, and extracellular region part) while in 6 cases there
was over-representation of differentially-expressed genes in blood
(zinc ion binding, phosphotransferase activity - alcohol group as
acceptor, biopolymer metabolic process, signal transduction,
nucleus, and cell communication).
Differentially Expressed Pathways
Pathway Express software identified 33 pathways that were
preferentially represented in the group of differentially expressed
genes (Table S2). Among these were 6 pathways from the immune
system group. Two pathways (complement and coagulation
cascades, hematopoietic cell lineage) contained more upregulated
genes in the endometrium than in the blood whereas three (toll-
like receptor signaling, Fc epsilon RI signaling, and B cell receptor
signaling) contained more upregulated genes in the blood. The
pathway with the greatest impact factor, leukocyte transendothe-
lial migration, was represented by 6 genes upregulated in
endometrium and 6 upregulated in blood.
Differentially Expressed Genes Characteristically
Regulated During Macrophage Differentiation
To determine the maturational state of endometrial macro-
phages as compared to blood monocytes, we evaluated which
genes that are regulated during macrophage differentiation are
differentially regulated between endometrial and blood CD14
+
cells. The data set used as reference was developed by Martinez et
al. [23]. In that study, human blood monocytes were cultured with
CSF1 for 3 d (intermediate differentiation) or 7 d (full differenti-
ation) to drive differentiation of monocytes to macrophages.
Subsequently, CSF1 treated cells were cultured with either IFNG
and lipopolysaccharide to cause differentiation to the classically-
activated or M1 phenotype or IL4 to cause differentiation to the
alternatively-activated or M2 phenotype (Figure 3).
The list of differentially-regulated genes in the current data set
for which orthologs exist in the data set of Martinez et al. [23] are
listed in Table S3 and a schematic representation of numbers of
differentially-expressed genes identified by Martinez et al. [23]
that were also upregulated in endometrium and blood is in
Figure 3. Of 128 genes that were differentially expressed in
monocytes after intermediate differentiation [23] 11 were
differentially expressed between endometrium and blood (9
overexpressed in endometrium and 2 in blood). Of 120 genes
differentially regulated after full differentiation [23], expression of
21 genes were higher in the endometrium and 4 were higher in the
blood. Of 62 genes upregulated in M1 macrophages [23], 1 gene
was upregulated in the endometrium and 3 were upregulated in
the blood. Of 51 genes upregulated in M2 macrophages, 7 genes
were upregulated in the endometrium and 1 gene was upregulated
in the blood.
Comparison to Genes Expressed by Human Decidual
Macrophages
In the human, decidual macrophages possess a unique pattern
of gene expression as compared to monocytes [21]. We asked if the
genes that are upregulated or downregulated in human decidual
macrophages are also differentially regulated in bovine endome-
trial macrophages. A total of 90% (107 of 120) of the genes found
to be differentially-expressed in human decidual macrophages
were present in the current data set. Of the 80 genes identified to
be upregulated in decidual macrophages [21], 19 genes were
significantly higher in the endometrium and 2 were higher in the
blood. Of the 40 upregulated in blood monocytes [21], 3 genes
were significantly higher in the blood and none were higher in the
endometrium. The list of these genes is in Table 1.
Quantitative RT-PCR
To validate the findings of the microarray analysis, qPCR was
performed for 11 differentially expressed genes and a housekeep-
ing gene (RPL19 – bovine ribosomal protein L19). Analyses were
performed on two sets of samples of mRNA. The first set was
composed of mRNA from two pairs of endometrial and blood
CD14
+ cells that were used in the microarray because there was
Endometrial Macrophages
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The second set was composed of mRNA from an additional three
pairs of endometrial and blood CD14
+ cells that were not used for
the microarray analysis.
In the first analysis (Table 2), with samples used in the
microarray, 7 of 11 genes were significantly affected by tissue type
[PAG10; GZMA; HMOX1; MRC1; RNASE6; TSGA14; FCGR3A]. In
each case, expression was higher in endometrium, in agreement
with results of the microarray analysis. In addition, an additional
gene, SLCO2B1, tended to be higher in the endometrium (7.2-
fold; P=0.09). This gene was also more highly expressed in
endometrium in the microarray analysis. Amounts of mRNA as
determined by qPCR were not affected by tissue type for two other
genes (PTX3 and MCP1). In both cases, the fold-change was
numerically higher for endometrium whereas, in the microarray
analysis, expression was higher in blood.
For the group of independent samples (Table 2), 4 genes were
significantly upregulated in endometrium compared with the
blood (PAG10; GZMA, TSGA14 and HMOX1) and all of these genes
were higher in the endometrium in the microarray analysis. An
additional 5 genes show differences in the same direction as for the
microarray although differences were not significant (MCP1,
RNASE6, SLCO2B1, PTX3 and MCP1). Two genes were not
significantly affected by tissue and differences were in the opposite
direction as for the microarray analysis (CD163, CD16).
Discussion
That accumulation of macrophages in the endometrium is
widespread phylogenetically and of large magnitude [1–8] is
evidence that these immune cells play an important role in
supporting the growth and survival of the conceptus. Using global
Figure 3. Graphical representation of differentially regulated genes in endometrial and blood CD14
+ cells that have been reported
to be differentially regulated during macrophage differentiation. Martinez et al. (23) identified genes that are differentially expressed in
monocytes after 3 (intermediate differentiation; A) or 7 days (full differentiation; B) of culture with CSF1 to cause differentiation into macrophages.
Afterwards, macrophages were polarized towards the classical activation (M1) pathway [C, achieved by culture with interferon-c (IFNG) and
lipopolyssacharide (LPS)) or alternative activation (M2) pathway (D, achieved by culture with interleukin 4 (IL4)). For each stage of differentiation, bars
represent the number of genes in the Martinez et al. (23) data set that were found in the present data set of endometrial and blood CD14
+ cells.
Genes that are upregulated in endometrium are in green, genes upregulated in blood are in red, and genes that were not significantly upregulated
are in black.
doi:10.1371/journal.pone.0013213.g003
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PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13213transcriptomal analysis, macrophages in the interplacentomal
endometrium of the cow exhibit patterns of gene expression that
suggest important roles in immune regulation, tissue remodeling,
angiogenesis, and apoptosis. Moreover, these functional properties
are likely to be a general feature of endometrial macrophages and
not a specific role of these cells in the cow because the pattern of
genes that are differentially regulated in endometrial macrophages
of the cow is similar to genes that are differentially regulated in
decidual macrophages in the human [21].
To assess gene expression, cells expressing CD14 were purified
from endometrium and blood. CD14 is a co-receptor for bacterial
lipopolysaccharide and is expressed on monocytes, macrophages
and neutrophils [24,25]. Previously [7,8], CD14
+ cells in
endometrium of pregnant cows were identified as macrophages
because they also express CD68, a lysosomal-associated protein
that is expressed on monocytes, macrophages and dendritic cells
[26]. In the present study, endometrial CD14
+ cells had a pattern
of gene expression that was largely similar to that of blood CD14
+
cells (Figure 1A). Moreover, given the similarity in gene expression
between endometrial and blood CD14
+ cells, it is likely that the
massive infiltration of CD14
+ cells in the pregnant endometrium is
a result of the recruitment from blood monocytes. Interestingly,
the proportion of peripheral blood mononuclear cells that are
monocytes decreases in late pregnancy in the cow [7], possibly as a
result of recruitment to the endometrium.
The pattern of differential gene expression is indicative of
changes in cell migratory function as monocytes move from blood
to endometrial stroma. Blood monocytes appear to have a high
capacity for responsiveness to external signals that ensures
activation of migration into tissues upon chemotactic signals from
tissues. There was a preponderance of upregulated genes in blood
for several differentially-regulated pathways involved in cell
signaling including toll-like receptor signaling, Fc epsilon RI
signaling, B cell receptor signaling, phosphatidylinositol signaling,
JAK-STAT signaling, MAPK signaling, wnt and cytokine-
cytokine receptor signaling and ErbB signaling (Table S2). Among
Table 1. Differentially expressed genes in endometrial and blood CD14
+ cells that are also differentially expressed in human
decidual macrophages vs human blood monocytes.
a
Description Accession Intensity Fold change P Tissue
b
Endometrium Blood
Upregulated genes in decidual macrophages
Granzyme A (GZMA) NM_001001142 33196 276 120 0.00 Endo
Solute carrier organic anion transporter family,
member 2B1 (SLCO2B1)
NM_174843 8667 173 50 0.00 Endo
Ribonuclease, RNase A family, 1 (RNASE1) NM_001014386 5671 124 46 0.01 Endo
Secreted phosphoprotein 1 (SPP1) NM_174187 4939 154 32 0.00 Endo
Collagen, type III, alpha 1 (COL3A1) XM_588040 430 15 29 0.02 Endo
Mannose receptor, C type 1 (MRC1) NM_002438 2246 93 24 0.00 Endo
Protein S (alpha) (PROS1) NM_174438 1670 72 23 0.00 Endo
V-set and immunoglobulin domain containing 4 (VSIG4) XM_865690 590 29 20 0.01 Endo
Complement component 1, q subcomponent, alpha
polypeptide (C1QA)
NM_001014945 15126 793 19 0.00 Endo
Apolipoprotein E (APOE) NM_173991 3576 208 17 0.00 Endo
Leprecan-like 1 (LEPREL1) XM_589206 1776 125 14 0.03 Endo
Complement component 1, q subcomponent, beta
polypeptide (C1QB)
XM_869694 29681 2122 14 0.00 Endo
Collagen, type I, alpha 2 (COL1A2) NM_174520 892 72 12 0.04 Endo
Chemokine (C-C motif) ligand 8 (CCL8) NM_174007 9546 1735 6 0.03 Endo
Chemokine (C-C motif) ligand 2 (CCL2) NM_174006 18786 3526 5 0.01 Endo
NKG2C protein (NKG2C) NM_001098163 665 139 5 0.03 Endo
Nerve growth factor receptor (TNFRSF16) associated protein 1
(NGFRAP1)
NM_014380 6512 1418 5 0.03 Endo
Endothelial PAS domain protein 1 (EPAS1) NM_174725 7981 2114 4 0.05 Endo
Transmembrane protein 97 (TMEM97) NM_001034403 6653 3454 2 0.05 Endo
Stathmin 1/oncoprotein 18 (STMN1) XM_589478 384 2113 6 0.05 Blood
Nicotinamide riboside kinase 1 (LOC510456) XM_587597 166 422 3 0.05 Blood
Upregulated genes in blood monocytes
Selenoprotein X, 1 (SEPX1) NM_001034810 7361 19546 3 0.03 Blood
Dipeptidase 2 (DPEP2) XM_586714 140 328 2 0.05 Blood
Benzodiazapine receptor (peripheral) (BZRP) NM_175776 2367 5508 2 0.04 Blood
aThe list of genes that are differentially regulated in human tissues are obtained from reference 21.
bTissue with higher expression in the current experiment. Endo signifies that expression was higher for endometrial CD14
+ cells whereas Blood signifies higher
expression in blood CD14
+ cells.
doi:10.1371/journal.pone.0013213.t001
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into tissues are various cytokine receptors (Table S2). One
pertinent gene is integrin alpha 4 (ITGA4), that encodes for the
alpha 4 subunit of the VLA-4 receptor and which promotes
transendothelial migration by interacting with endothelial cell
surface receptors VCAM-1 and JAM2 [27]. Another is the gene
for the nuclear repressor protein glucocorticoid receptor DNA
binding factor-1 (GRLF1) that antagonizes the inhibitory effect of
TGFB1 on monocyte migration [28]. Several genes involved in
cell motility were also upregulated in blood including several
myosin genes (MYL2, MYLPF, and MYH10) and two regulators of
the actin cytoskeleton, diaphanous homolog 1 (DIAPH1) and
paxillin (PXN).
Once macrophages are in the endometrium, the above-
mentioned genes involved in cell signaling and diapedesis become
downregulated. Other genes involved in motility increase, including
thymosin beta 4 (TMSB4X), which promotes cell motility through
sequestration of G-actin monomers during actin-cytoskeletal
organization [29] and enabled homolog (ENAH), which blocks
capping of actin filaments and promotes filopodia formation [30].
These changes may indicate a different pattern of cell motility once
monocytes enter the endometrium. At the same time, endometrial
CD14
+ cells gain increased capacity for interacting with other
cellular and extracellular components of the endometrium as
indicated by increased expression of genes encoding for cell
adhesion molecules and ECM-receptor interaction pathways (Table
S2). Cell adhesion proteins on endometrial macrophages likely
function to facilitate regulation of other immune cells. For example,
E-cadherin (CDH1), a gene upregulated in endometrium, promotes
macrophage – T cell interactions [31].
Endometrial CD14
+ cells may themselves promote migration of
monocytes and other leukocytes into the endometrium as
indicated by upregulation of CXCL14 and chemokines CCL8,
CCL22 and CCL24. The platelet derived growth factor B
polypeptide (PDGFB) was also upregulated in endometrium.
PDGF directs movement of neutrophils and macrophages [32].
Despite the identification of CD14
+ cells as macrophages, some
of the upregulated genes in endometrium were placental and
uterine genes such as pregnancy associated glycoproteins [33],
prolactin related proteins [34] and uterine serpin [35]. Endome-
trial CD14
+ cells were 90–95% pure, and the presence of placental
or endometrial genes could reflect contamination of the CD14
+
population with trophoblast, endometrial epithelium or endome-
trial stroma. In species where endometrium undergoes a decidual
response, decidualized stroma express cytokines and chemokines
characteristically secreted by immune cells [36,37]. Perhaps
similar differentiation pathways exist in species like cattle so that
CD14 becomes upregulated in non-myeloid cells.
Once migrating into the endometrium, at least a subset of
CD14
+ monocytes undergo differentiation. This is so because
many of the genes identified by Martinez et al. [23] as being
upregulated in macrophages during differentiation were upregu-
lated in endometrial CD14
+ cells as compared to CD14
+ cells in
blood. We hypothesized that, in the absence of infection,
endometrial macrophages would be preferentially activated along
the M2 activation pathway so that that differentiation results in
macrophages that promote inhibition of inflammation, angiogen-
esis, and tissue remodeling [38–40]. Indeed, as detailed in the next
paragraphs, there is evidence for bias of endometrial macrophages
towards M2 activation. Nonetheless, it is likely that there is more
than one subpopulation of endometrial macrophage resident in
the endometrium of pregnant cows. Some subpopulations of
endometrial macrophages may undergo a differentiation process
that is unique for that tissue.
Seven of 51 genes upregulated in M2 activated macrophages
[23] were upregulated in endometrial CD14
+ cells. One of these
genes was glycine amidinotransferase (GATM) which competes
with the inducible form of nitric oxide synthase for arginine and
thereby reduces production of the proinflammatory molecule
nitric oxide [41]. Two C-type lectins characteristically activated in
M2 macrophages, mannose receptor C1 (MRC1) and C-type lectin
domain family 7, member A (CLEC7A or dectin-1) were also
upregulated in endometrial CD14
+ cells. Activation of MRC1 can
lead to inhibition of secretion of IL12 (stimulates NK cell and T-
cells) and increased secretion of the anti-inflammatory cytokines
IL8, IL10, IL1 receptor antagonist and IL1 receptor type II [42].
In contrast, CLEC7A, which recognizes fungal carbohydrates, can
participate in release of inflammatory cytokines [43]. Another
gene upregulated in endometrium was prostaglandin G/H
synthase (PTGS1 or cyclooxygenase 1) which is a key enzyme in
prostaglandin, prostacyclin, and thromboxane A2 biosynthesis.
These eicasonoids have been implicated in immunosuppression
(prostaglandin E2) and angiogenesis (prostaglandins E2, I2, F2a,
and thromboxane A2) [44].
The one upregulated gene in endometrium that could be
classified as characteristic of M1 macrophages (complement factor
B, CFB) also encodes for a protein that can have anti-inflammatory
properties. Cleavage of CFB by complement factor D liberates the
Ba fragment that inhibits proliferation of B cells [45].
In addition to the genes identified by Martinez et al. [23], other
genes expressed in M2 macrophages were upregulated in
endometrium including CD163, which is a scavenger receptor
that, in its soluble form, exerts anti-inflammatory actions [46] as
well as the anti-inflammatory cytokines CCL22 and CCL24 that are
produced by M2a macrophages [39]. CCL2, an M1 cytokine [39],
was also upregulated in endometrium. Another gene upregulated
in M2 macrophages, E-cadherin (CDH1), was one of the top 100
upregulated genes in the endometrium. This cell adhesion protein
promotes macrophage fusogenic activity and macrophage – T cell
interactions [31]. Two other genes with anti-inflammatory activity
were upregulated in endometrium. TMSB4 can be oxidized by
macrophages exposed to glucocorticoteroids to form thymosin b4
sulfoxide that has anti-inflammatory properties [47]. Fibroblast
growth factor 1 (FGF1), another gene upregulated in endometri-
um, inhibits expression of monocyte adhesion molecules on
endothelial cells involved in transendothelial movement and may
be anti-inflammatory [48].
One function of M2 macrophages is to promote tissue
remodeling [40] and analysis of the transcriptome of endometrial
vs blood CD14
+ cells is consistent with endometrial CD14
+ cells
being actively involved in this process. There was over-
representation of differentially-expressed genes in endometrium
for three ontologies related to proteolysis (peptidase activity,
endopeptidase activity, and proteolysis).
The upregulation of granzymes (gzma, GZMA and GZMB)i n
endometrial CD14
+ cells is consistent with a role for these cells in
induction of apoptosis. Apoptotic cells are common in the
placenta, especially at the edges of the placentomes and in the
interplacentomal region [49]. While the bovine trophoblast is
considered to be non-invasive and not capable of crossing the
basement membrane of the luminal epithelium of the endometri-
um, it is possible that endometrial macrophages remove placental
cells that stray past this barrier. Apoptosis could also be a signal for
regulation of macrophage function. Abrahams et al. [50]
hypothesized that ingestion of apoptotic trophoblast cells causes
decidual macrophages to develop an immunosuppressive pheno-
type. Another possible interpretation of the upregulation of
granzymes is that a portion of the CD14
+ cells in endometrium
Endometrial Macrophages
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contain granzyme A [51].
Validation of microarray results with qPCR validation resulted
in differential expression being confirmed for 7 of 11 genes
evaluated. Examination of differences between endometrial and
blood CD14
+ cells using qPCR of an independent data set
indicated a smaller degree of agreement with microarray results (4
of 11 genes) but a total of 9 of 11 genes showed differences in the
same direction as the results from microarray hybridization. The
independent samples were from a slightly earlier stage of
pregnancy and this fact could have resulted in some discrepancies
with the microarray data set.
In summary, endometrial CD14
+ cells express genes character-
istically found in macrophages. Moreover, analysis of the
transcriptome of these cells indicates that at least a subpopulation
of the cells differentiates along an M2 activation pathway and that
the cells play roles in immune regulation, tissue remodeling,
angiogenesis, and apoptosis. These roles are likely of broad
relevance to mammalian reproduction rather than to be specific
properties of pregnancy in the cow. Endometrial macrophages in
the human also undergo M2 activation [3,21]. In addition, 20% of
the genes found by Gustafsson et al. [21] to be differentially
expressed between decidual and blood macrophages were also
differentially expressed in the same direction in cow. Thus, despite
substantial evolutionary divergence in reproductive patterns, the
properties of the endometrial macrophage during pregnancy have
been at least partially conserved.
Materials and Methods
Materials
Mouse anti-bovine CD14 (clone MM61A, clarified ascites fluid,
10 mg/ml) was obtained from VMRD, Inc. (Pullman, WA, USA).
The Ab was tagged with labeled Fab fragments against mouse IgG
conjugated to Alexa Fluor 488 using the ZenonH Mouse Labeling
IgG kit from Invitrogen Molecular Probes (Eugene, OR, USA) as
per manufacturer’s instructions.
Fico/Lite LymphoH was purchased from Atlanta Biologicals
(Norcross, GA, USA). Fetal bovine serum was purchased from
Sigma-Aldrich (St. Louis, MO, USA) or Pel-Freez Biologicals
(Rogers, AR, USA). Tissue Culture Medium-199 (TCM-199),
bovine serum albumin (BSA) Fraction-V, Dulbecco’s PBS (DPBS),
and collagenase type I was purchased from Sigma-Aldrich (St.
Louis, MO, USA). Other reagents were from Sigma-Aldrich or
Fisher Scientific (Pittsburgh, PA, USA).
Collection of Endometrium and Blood
For microarray analysis, the uterus and cardiac blood were
obtained at the time of euthanasia at a local abattoir from four
cows at an estimated 164, 239, 242 and 248 days of pregnancy,
respectively (i.e., dating based on fetal crown-rump length [52]).
Blood was collected into heparinized tubes. Blood and the uterus
were transported to the lab on ice within 1.5 h after slaughter. The
uterus and cardiac blood from three additional cows at an
estimated 156, 169 and 176 days of pregnancy were collected as
described above for RNA collection to be used for quantitative real
time PCR (qPCR) analysis.
Isolation of Mononuclear Leukocytes in Blood
PBMCs were obtained from blood as follows. Blood (10 ml) was
centrifuged at 600 g for 30 min to obtain the buffy coat. This layer
was mixed with 2 ml TCM-199 and the cell suspension was
transferred to the top of 2 ml Fico/Lite LymphoH placed in a
15 ml conical tube. Cells were centrifuged at 600 g for 30 min.
Mononuclear cells were collected at the interface of the Fico/Lite
LymphoH and media, centrifuged at 600 g for 10 min, resus-
pended in DPBS, and evaluated with a hemacytometer to
determine cell concentration and viability (trypan blue exclusion).
Cells were resuspended to a final concentration of 5610
7/ml in
staining buffer (DPBS supplemented with 0.1% (w/v) BSA).
Preparation of Cell Suspension from Endometrium
A suspension of cells was prepared from interplacentomal
endometrium dissected from the uterine horn containing the fetus.
Dissected endometrium was finely minced in DPBS using a sterile
scalpel blade and a petri dish and then placed into a 50 ml sterile
culture tube containing 25 ml digestion medium (TCM-199
supplemented with 150 U/ml type I collagenase). Tissue was
incubated at 37uC under gentle rotation for 15 min. Undigested
tissue was allowed to settle for 5 min; the supernatant fraction was
then collected by aspiration, and 25 ml of fresh digestion medium
was added to the tissue fraction. The remaining tissue was
incubated for an additional 15 min under rotation, and the
supernatant fraction produced after settling was pooled with the
previous supernatant fraction. Cells in suspension in the
supernatant fraction were collected by filtration through a sterile
100 mm cell strainer into 50 ml sterile culture tubes. Cells were
centrifuged at 1106g for 5 min, resuspended in 5 ml TCM-199
supplemented with 10% (v/v) fetal bovine serum, analyzed for cell
number using a hemacytometer, and diluted to a final concentra-
tion of 5610
5/ml in TCM-199. A 10 ml aliquot of the dispersed
endometrial cell suspension was layered onto 5 ml Fico/Lite
LymphoH in a 15 ml conical tube. Cells were centrifuged at 600 g
for 30 min. The interface containing mononuclear cells was
collected and resuspended in 10 ml of staining buffer, washed
once, resuspended in staining buffer, and evaluated for cell
concentration and viability (trypan blue exclusion) using a
hemacytometer. Cells were then resuspended to a final concen-
tration of 5610
6/ml.
Purification of CD14
+ Cells
Endometrial cells and PBMC were separately subjected to flow
cytometry and cell sorting to prepare CD14
+ cells. The entire pool
of cells obtained as described above was placed into a 15 ml
conical tube containing staining buffer, washed twice with 5 ml
staining buffer, and resuspended in the smallest volume possible
with staining buffer. Cells were then labeled by incubation with
Zenon-labeled anti-CD14 by adding 0.1 mg labeled Ab per 5610
6
cells. A Zenon-labeled mouse IgG1 at the same concentration as
the primary Ab was incubated with another aliquant of cells to
determine nonspecific labeling. Cells and labeled Ab were
incubated at room temperature for 30 min. After incubation, cells
were diluted to 5 ml with staining buffer to 5610
6 cells/ml and
subjected to cell sorting using flow cytometry with a FACSCAria
Cell Sorter supported by DiVa software V.6.1.2 (BD Biosciences,
San Jose, CA, USA). Sorting was performed with a 100 micron
nozzle and pressure of 20 psi. Cells were gated on the basis of
forward and side scatter to analyze the monocyte region. Two
rounds of cell sorting were performed. The first round of sorting,
at a high flow rate, was performed to maximize yield of CD14
+
cells while the second step was designed to maximize purity of the
CD14
+ cells at low flow rate.
RNA Purification
Sorted CD14
+ cells were centrifuged at 600 g for 5 min and
total cellular RNA was extracted using the using the RNeasy
Micro kit (Qiagen Inc, Valencia, CA, USA). Concentration of
total cellular RNA was determined using the Nanodrop 1000
Endometrial Macrophages
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integrity determined by Agilent 2100 Bioanalyzer with RNA
6000 Pico LabChip kit (Agilent Technologies, Santa Clara CA,
USA). Only samples that showed high RNA integrity (RIN .7)
were used for the microarray hybridization and quantitative PCR
analysis. Extracted RNA was stored at 280uC until microarray
analysis.
Microarray Hybridization
Four pairs of samples of blood and endometrial CD14
+ cells
were subjected to transcriptional profiling using the Bovine Oligo
Microarray Chip (Bovine 4X44K G2519F) from Agilent (Santa
Clara CA, USA). Each pair was collected from the same animal.
The array contains 43,803 bovine probes representing 20,767
unique 60-mer probes and approximately 19,500 distinct bovine
genes arranged on a slide as 4 arrays in a 4X44K format. The
probes were developed by clustering more than 450,000 mRNA
and EST sequences of the bovine genome (btau 2.1). All
microarray protocols were carried out by Mogene LLC (St. Louis,
MO, USA), an Agilent Certified Service Provider.
Prior to microarray hybridization, 10–50 ng of total RNA were
amplified using the WT-Ovation Pico RNA Amplification Kit
(NuGen Technologies, Inc, San Carlos, CA, USA) according to
the manufacturer’s protocol. Two micrograms of amplified
Table 3. Primer/probe sets used for qRT-PCR.
Gene Name Accession
Primer/
Probe Sequence (59-39)
CD163 molecule (CD163) NM_001077402 forward
a AAT TTC GTG GAC AGA GTT CTC
probe
b /56-FAM/AGA CAG CGG CTT GCA GTT TCC/3IABlk_FQ
reverse
c AAT TTC GTG GAC AGA GTT CTC
Mannose receptor C1 (MRC1) XM_001252128 forward
a TCG AGT TGA GCC ACT TCA
probe
b /56-FAM/CCA CAC CCA CAT TCC TTC AAC ATT TCT/3IABlk_FQ/
reverse
c TCT TTC ACC AGA GGG ATC AC
Granzyme A (GZMA) NM_001001142 forward
a AAG ACG CTA CAT GGC TCT
probe
b /56-FAM/CGC TCA TTG TGA CCT GAA GGG C/3IABlk_FQ/
reverse
c ATG GGA TGT AGA GTG GGC
Heme oxygenase (decyclizing) 1 (HMOX1) NM_001014912 forward
a CGG AGA ATG CAG AGT TCA
probe
b /56-FAM/AAG GTT TTA AGC TGG TGA TGG CGT C/3IABlk_FQ/
reverse
c TGT TGC GTT CGA TCT CCT
Chemokine (C-C motif) ligand 2; CCL2 (MCP1) XM_614752 forward
a AGA GGC TGT GAT TTT CAA GAC
probe
b /56-FAM/AGT TAT GTG CAG ACC CCA AGC AGA/3IABlk_FQ/
reverse
c GGT TGT GGA GTG AGT GCT
Fc fragment of IgG, low affinity IIIa,
receptor (CD16A)
NM_001077402 forward
a GAA TGG AGG GAT GGC AAA
probe
b /56-FAM/TTA GGA CAA ATG GAG GCA TCT CTG GG/3IABlk_FQ/
reverse
c ACA GAG TTG GGT GAA GGA TC
Ribonuclease k6 (RNASE6) NM_174594 forward
a CCC CTT ATC ATT TGG TTC CTG
probe
b /56-FAM/AGG TTG TTT AAA TCA CTT TGC TTC TCG CT/3IABlk_FQ/
reverse
c AAA TCA ATA AAA GAC AAG AAA ATC AGA G
Testis specific, 14 (TSGA14) XM_583431 forward
a AGA ATC CCC GCT CAC TG
probe
b /56-FAM/CAA GGT CCT TTA CTT CCA GGG TTT GC/3IABlk_FQ/
reverse
c GAA AAC ATT TAT TTG ACT AAG GCA G
Pregnancy-associated glycoprotein 10 (PAG10) NM_176621 forward
a GCC CAA GCT TAC ATC CAA AG
probe
b /56-FAM/TCT CCG ACT CGT TCA CAC GCT/3IABlk_FQ/
reverse
c GAG AAA TAC AGC CTC AGG AAG
Solute carrier organic anion transporter family,
member 2B1 (SLCO2B1)
NM_174843 forward
a ATC CAG AGT GTG AGC TGT
probe
b /56-FAM/CCC AAT ACC CAA TTC CAG GCA AAG G/3IABlk_FQ/
reverse
c CAA GTT AGC GGA AGA CTC AC
Ribosomal protein L19 (RPL19) NM_001040516 forward
a CTG AAG GTG AAG GGT AAC G
probe
b /56-FAM/AGG CAG ACA AGG CTC GCA AGA/3IABlk_FQ/
reverse
c GGG CTT CCT TGG TCT TAG A
aForward=sense (59) primer.
bEach probe was synthesized with a 59 6-FAM reporter dye and 39 IA-Black quencher.
cReverse=antisense (39) primer.
doi:10.1371/journal.pone.0013213.t003
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DNA Enzymatic Labeling Kit (Agilent Technologies, Santa Clara
CA, USA) and 1.5 mg of each labeled sample were co-hybridized
to the array for 17 h at 65uC at 10 rpm in a rotating oven in an
ozone-free room using SureHyb chambers from Agilent (Agilent
Technologies, Santa Clara CA, USA). Wash conditions were as
outlined in the Agilent processing manual and the arrays were
scanned using an Agilent G2505B scanner (Agilent Technologies,
Santa Clara CA, USA). Two technical replicates were performed.
For the first replicate, RNA samples from blood were labeled with
Cy3 and RNA from endometrium was labeled with Cy5. For the
second technical replication, 3 samples of RNA from blood were
labeled with Cy5 and their matching pairs of RNA from
endometrial were labeled with Cy3 while the fourth pair used
Cy3 for blood and Cy5 for endometrium.
Analysis of Microarray Data
The microarray image extraction and data pre-processing were
performed using Agilent’s Feature Extraction software v 9.5
(Agilent Technologies, Santa Clara CA, USA). The intensity of
each spot was summarized as the median pixel intensity followed
by log transformation. The lowess normalization was done within-
array lowess on median of the intensities of the spots. The JMPH
Genomics 3.1 for SASH 9.1.3 software (SAS Inst., Inc., Cary, NC)
was used. The quantile normalization method for data global
normalization was performed. Differentially regulated genes were
identified by least-squares ANOVA by the PROC ANOVA
procedure of JMPH Genomics 3.1 for SASH 9.1.3. The model
included animal, replicate, and tissue source (blood or endome-
trium). Fixed effects included tissue and replicate and random
effects included animal. Tissue x animal was the error term for
tissue. Correction for false discovery rate was performed by the
Benjamini and Hochberg method [53] with a maximum false
discovery rate of 0.01. Genes with a minimum intensity of 16 were
considered to be expressed. Only genes with at least 2-fold
difference and a probability of P#0.05 for a tissue difference were
considered differentially expressed. Expression values were
deposited in the Gene Expression Omnibus repository as Series
number GSE20190 (www.ncbi.nlm.nih.gov/geo/).
Gene Ontology Analysis
An analysis was performed using FatiGo (a web-based program
for functional profiling; www.babelomics.org) to indentify func-
tional enrichment by comparing the two lists of differentially
regulated genes from endometrium and blood by means of a
Fisher’s exact test [54]. Furthermore, Pathway Express (http://
vortex.cs.wayne.edu/ontoexpress) was used to identify relevant
pathways represented by the differentially regulated gene set.
Pathway Express calculates a probability (P) value, based on the
density of genes that belong to a determined pathway using the
Kyoto Encyclopedia of Gene and Genome database [55]. It also
calculates a gamma P value using the perturbation factor for each
input gene in the pathway that accounts for the normalized fold
change of the gene and the number and the amount of
perturbation of genes at downstream positions on the pathway.
Both P- and gamma P-values are combined to generate the impact
factor which was used to rank the pathways according to their
biological significance. A pathway was considered to be signifi-
cantly affected by tissue source if the gamma P-value #0.05.
Quantitative Real-Time PCR
Quantitative PCR was performed on 11 genes found to be
differentially expressed by microarray hybridization as well as a
housekeeping gene used as an internal control (bovine ribosomal
protein L19; RPL19). Samples from a total of five pairs were
analyzed by qPCR. These included 2 pairs of samples that were
also used for the microarray analysis and 3 pairs of new samples.
We could not use samples from all 4 pairs used in the microarray
analysis for the qPCR validation due to insufficient quantities of
RNA.
Primers and probes are shown in Table 3. The qPCR analyses
were carried out by Mogene LLC. The hydrolysis probe based
system was designed using the online tool ‘‘PrimeTime qPCR
Assays’’ by IDT DNA (www.idtdna.com) and the primers and
probes were purchased from the same company. The final primer
and probe concentration was 200 nM. All probes had a 59 6-Fam
label and a 39 IA-Black Quencher. The reaction was designed for
a total reaction volume of 25.0 ml. The template cDNA (25 ng per
reaction) was added to each reaction in 5.0 ml. The Applied
Biosystems Taqman Gene Expression Mastermix (Foster City,
CA, USA) was used. Cycling conditions were 95uC for 10 min,
and 40 cycles at a 95uC melting temperature for 15 sec. and 60uC
for 1 min. Each sample was assayed in 3 replicates.
The level of expression of each tested gene was calculated using
the DCt method with normalization to the RPL19 housekeeping
gene. Treatment effects were analyzed by least squares analysis of
variance using the General Linear Models procedure of SAS (SAS
for Windows, version 9.3, SAS Institute Inc., Cary, NC, USA).
The animal x tissue interaction term was used as the error to test
effect of tissue. Results are presented as least-squares means 6
standard errors.
Supporting Information
Table S1 Ontologies where the incidence of frequency of
overexpressed genes in the endometrium was different than the
incidence of overexpressed genes in the blood.
Found at: doi:10.1371/journal.pone.0013213.s001 (0.08 MB
PDF)
Table S2 Pathways subject to differential regulation.
Found at: doi:10.1371/journal.pone.0013213.S002 (0.11 MB
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Table S3 Differentially regulated genes in endometrial and
blood CD14+ cells that were also differentially regulated in the
intermediately-differentiated, fully differentiated, M1 and M2
activated macrophage.
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